erlotinib, gefitinib, afatinib, osimertinib
What are EGFR inhibitors? (4)
forms an irreversible/covalent bond with a groove near K-RAS mutation locking it into off state
Sotorasib MOA?
GTP; GDP
K-RAS turns on when _____ binds to it & off when ______ binds to it.
Tyr-K domain; competitive inhibition; ATP
EGFR inhibits the ________ by ________ of __________ binding.
c
Which is a humanized mAB?
a) Erlotinib
b) Sotorasib
c) Bevacizumab
d) Ipilimumab
immature; VEGF
Tumor vessels are ________ and depend on _______ to mature and
stabilize.
prevent new vessels + destroys recent ones
What is Anti-VEGF function? (2)
bevacizumab
What is our VEGF inhibitor?
recognize/destroy neoplastic cells before they become clinically meaningful
What is the role of the immune system?
CTLA-4; PD-1
What are the Immune checkpoints? (2)
T-cell death; inactivation
Activation of immune checkpoints leads to ________ or _________.
act on T-cells & prevent their inactivation
Anti-PD-1 MOA?
act on the ligand expressed by tumor cells that inactivates T-cells
Anti-PD-L1 MOA?
nivolumab, pembrolizumab
What are the Anti- PD1 inhibitors? (2)
atezolizumab, durvalumab
What are the Anti- PD- L1 inhibitors? (2)
ipilimumab
What is the CTLA-4 inhibitor?
blocks CTLA-4 suppressive signal; maintains T-cell activation
CTLA-4 inhibitor MOA?
resistance eventually develops
What is the problem with BRAF-mutation therapeutics?